TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 92 filers reported holding TRINITY BIOTECH PLC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $2,379,000 | -7.1% | 131,719 | -1.0% | 0.14% | -7.4% |
| Q1 2015 | $2,560,000 | +20.4% | 132,995 | +9.5% | 0.15% | +14.7% |
| Q4 2014 | $2,126,000 | -4.4% | 121,416 | -0.3% | 0.13% | -16.8% |
| Q3 2014 | $2,225,000 | -21.9% | 121,788 | -1.5% | 0.16% | -19.3% |
| Q2 2014 | $2,848,000 | -5.8% | 123,654 | -0.9% | 0.19% | -13.5% |
| Q1 2014 | $3,024,000 | +141.1% | 124,820 | +150.3% | 0.22% | +146.7% |
| Q4 2013 | $1,254,000 | – | 49,870 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACK Asset Management | 928,000 | $10,616,000 | 4.44% |
| GOLDMAN CAPITAL MANAGEMENT INC | 350,961 | $4,015,000 | 2.86% |
| Paradice Investment Management LLC | 992,235 | $11,351,000 | 2.07% |
| Centaur Capital | 77,500 | $887,000 | 1.33% |
| Adirondack Funds | 302,305 | $3,458,000 | 1.33% |
| Adirondack Research & Management Inc. | 302,305 | $3,458,000 | 1.33% |
| RK Capital | 565,472 | $6,469,000 | 1.18% |
| Lyon Street Capital, LLC | 140,943 | $1,612,000 | 1.17% |
| Benchmark Capital Advisors | 89,941 | $1,029,000 | 0.84% |
| KEANE CAPITAL MANAGEMENT INC | 55,045 | $630,000 | 0.83% |